HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bingmei M Fu Selected Research

Radioimmunotherapy

1/2014Quantification of transient increase of the blood-brain barrier permeability to macromolecules by optimized focused ultrasound combined with microbubbles.
8/2009A pharmacokinetic model for radioimmunotherapy delivered through cerebrospinal fluid for the treatment of leptomeningeal metastases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Bingmei M Fu Research Topics

Disease

18Neoplasms (Cancer)
05/2024 - 08/2009
7Neoplasm Metastasis (Metastasis)
05/2024 - 08/2009
6Breast Neoplasms (Breast Cancer)
01/2024 - 02/2010
4Brain Diseases (Brain Disorder)
10/2020 - 06/2012
1Carcinogenesis
05/2024
1DiGeorge Syndrome (Syndrome, DiGeorge)
01/2023
1Mental Disorders (Mental Disorder)
01/2021
1Hypoxia (Hypoxemia)
01/2020
1Hepatocellular Carcinoma (Hepatoma)
01/2019
1Alzheimer Disease (Alzheimer's Disease)
01/2018
1Relapsing-Remitting Multiple Sclerosis
06/2017
1Thrombosis (Thrombus)
04/2011
1Carcinoma (Carcinomatosis)
02/2010

Drug/Important Bio-Agent (IBA)

9Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2024 - 02/2010
2Heparitin Sulfate (Heparan Sulfate)IBA
01/2024 - 03/2022
2CytokinesIBA
01/2020 - 01/2016
2MicroRNAs (MicroRNA)IBA
01/2020 - 01/2019
2Cell Adhesion MoleculesIBA
01/2018 - 11/2012
2NeurotoxinsIBA
01/2018 - 06/2012
2AlbuminsIBA
01/2016 - 10/2012
2Proteins (Proteins, Gene)FDA Link
01/2016 - 10/2015
2Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
08/2011 - 02/2010
2IntegrinsIBA
08/2011 - 02/2010
2Bovine Serum AlbuminIBA
04/2011 - 02/2010
1Imatinib Mesylate (Gleevec)FDA Link
01/2023
1Phosphotransferases (Kinase)IBA
01/2023
1Hyaluronic Acid (Hyaluronan)IBA
03/2022
1Doxorubicin (Adriamycin)FDA LinkGeneric
11/2020
1Circular RNAIBA
01/2020
1Matrix Metalloproteinases (MMPs)IBA
01/2020
1AngiopoietinsIBA
01/2020
1Amyloid (Amyloid Fibrils)IBA
01/2018
1Dimethyl FumarateIBA
06/2017
14,5-diaminofluorescein diacetateIBA
01/2016
1LipopolysaccharidesIBA
01/2016
1omega-N-Methylarginine (NG Monomethyl L Arginine)IBA
01/2016
1Arginine (L-Arginine)FDA Link
01/2016
1Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2016
1Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
01/2016
1Adenosine (Adenocard)FDA LinkGeneric
01/2016
18-Bromo Cyclic Adenosine Monophosphate (8 Bromo Cyclic Adenosine Monophosphate)IBA
10/2015
1Monoclonal AntibodiesIBA
01/2014
1Intravenous Immunoglobulins (IVIG)FDA Link
01/2014
1Blood Proteins (Serum Proteins)IBA
11/2012
1Orosomucoid (Seromucoid)IBA
10/2012
1Glycoproteins (Glycoprotein)IBA
10/2012
1Phenobarbital (Luminal)FDA Link
04/2011
1tetramethylrhodamine isothiocyanateIBA
04/2011
1Coloring Agents (Dyes)IBA
04/2011
1LigandsIBA
02/2010
1Ringer's SolutionIBA
02/2010
1SU 1498IBA
02/2010
1Integrin alpha6IBA
02/2010
1AntigensIBA
08/2009
1AntibodiesIBA
08/2009

Therapy/Procedure

3Transcranial Direct Current Stimulation
01/2021 - 04/2020
3Therapeutics
01/2020 - 04/2012
2Radioimmunotherapy
01/2014 - 08/2009
1Physical Therapy Modalities (Physical Therapy Technique)
01/2021
1Microspheres (Microsphere)
06/2014
1Photochemotherapy (Photodynamic Therapy)
04/2011